Literature DB >> 33824394

How peptic ulcer disease could potentially lead to the lifelong, debilitating effects of chronic fatigue syndrome: an insight.

Chien-Feng Kuo1,2,3, Leiyu Shi4, Cheng-Li Lin5,6, Wei-Cheng Yao7, Hsiang-Ting Chen8, Chon-Fu Lio8, Yu-Ting Tina Wang8, Ching-Huang Su8, Nai-Wei Hsu1,8, Shin-Yi Tsai9,10,11.   

Abstract

Chronic Fatigue Syndrome (CFS) has been defined as unexplained relapsing or persistent fatigue for at least 6 consecutive months. Immuno-inflammatory pathway, bacterial infection, and other causes play essential roles in CFS. Helicobacter pylori infection is one of the most common causes of foregut inflammation, leading to peptic ulcer disease (PUD). This study aimed to analyze the risk of CFS development between patients with and without PUD. Other related factors were also analyzed. We performed a retrospective, nationwide cohort study identifying patients with or without PUD respectively by analyzing the Longitudinal Health Insurance Database 2000 (LHID2000), Taiwan. The overall incidence of CFS was higher in the PUD cohort than in the non- PUD cohort (HR = 2.01, 95% CI = 1.75-2.30), with the same adjusted HR (aHR) when adjusting for age, sex, and comorbidities. The sex-specific PUD cohort to the non-PUD cohort relative risk of CFS was significant in both genders. The age-specific incidence of CFS showed incidence density increasing with age in both cohorts. There is an increased risk of developing CFS following PUD, especially in females and the aging population. Hopefully, these findings can prevent common infections from progressing to debilitating, chronic conditions such as CFS.

Entities:  

Year:  2021        PMID: 33824394     DOI: 10.1038/s41598-021-87018-z

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  43 in total

Review 1.  Shared microglial mechanisms underpinning depression and chronic fatigue syndrome and their comorbidities.

Authors:  Adriano José Maia Chaves-Filho; Danielle S Macedo; David Freitas de Lucena; Michael Maes
Journal:  Behav Brain Res       Date:  2019-05-25       Impact factor: 3.332

2.  Inflammation correlates with symptoms in chronic fatigue syndrome.

Authors:  Anthony L Komaroff
Journal:  Proc Natl Acad Sci U S A       Date:  2017-08-15       Impact factor: 11.205

3.  A reboot for chronic fatigue syndrome research.

Authors:  Amy Maxmen
Journal:  Nature       Date:  2018-01-04       Impact factor: 49.962

Review 4.  Diagnostic Methods for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Systematic Review for a National Institutes of Health Pathways to Prevention Workshop.

Authors:  Elizabeth Haney; M E Beth Smith; Marian McDonagh; Miranda Pappas; Monica Daeges; Ngoc Wasson; Heidi D Nelson
Journal:  Ann Intern Med       Date:  2015-06-16       Impact factor: 25.391

Review 5.  The putative role of oxidative stress and inflammation in the pathophysiology of sleep dysfunction across neuropsychiatric disorders: Focus on chronic fatigue syndrome, bipolar disorder and multiple sclerosis.

Authors:  Gerwyn Morris; Brendon Stubbs; Cristiano A Köhler; Ken Walder; Anastasiya Slyepchenko; Michael Berk; André F Carvalho
Journal:  Sleep Med Rev       Date:  2018-04-04       Impact factor: 11.609

6.  Relationship Between Exercise-induced Oxidative Stress Changes and Parasympathetic Activity in Chronic Fatigue Syndrome: An Observational Study in Patients and Healthy Subjects.

Authors:  Andrea Polli; Jessica Van Oosterwijck; Jo Nijs; Uros Marusic; Inge De Wandele; Lorna Paul; Mira Meeus; Greta Moorkens; Luc Lambrecht; Kelly Ickmans
Journal:  Clin Ther       Date:  2019-01-18       Impact factor: 3.393

Review 7.  The clinical value of cytokines in chronic fatigue syndrome.

Authors:  Tiansong Yang; Yan Yang; Delong Wang; Chaoran Li; Yuanyuan Qu; Jing Guo; Tianyu Shi; Wang Bo; Zhongren Sun; Tetsuya Asakawa
Journal:  J Transl Med       Date:  2019-06-28       Impact factor: 5.531

8.  Increased risk of chronic fatigue syndrome in patients with inflammatory bowel disease: a population-based retrospective cohort study.

Authors:  Shin-Yi Tsai; Hsuan-Ju Chen; Chon-Fu Lio; Chien-Feng Kuo; An-Chun Kao; Wei-Shieng Wang; Wei-Cheng Yao; Chi Chen; Tse-Yen Yang
Journal:  J Transl Med       Date:  2019-02-22       Impact factor: 5.531

9.  Genetic Predisposition for Immune System, Hormone, and Metabolic Dysfunction in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Pilot Study.

Authors:  Melanie Perez; Rajeev Jaundoo; Kelly Hilton; Ana Del Alamo; Kristina Gemayel; Nancy G Klimas; Travis J A Craddock; Lubov Nathanson
Journal:  Front Pediatr       Date:  2019-05-24       Impact factor: 3.418

10.  Reduced diversity and altered composition of the gut microbiome in individuals with myalgic encephalomyelitis/chronic fatigue syndrome.

Authors:  Ludovic Giloteaux; Julia K Goodrich; William A Walters; Susan M Levine; Ruth E Ley; Maureen R Hanson
Journal:  Microbiome       Date:  2016-06-23       Impact factor: 14.650

View more
  4 in total

1.  Treatments of chronic fatigue syndrome and its debilitating comorbidities: a 12-year population-based study.

Authors:  Kam-Hang Leong; Hei-Tung Yip; Chien-Feng Kuo; Shin-Yi Tsai
Journal:  J Transl Med       Date:  2022-06-11       Impact factor: 8.440

2.  How mycobacterium tuberculosis infection could lead to the increasing risks of chronic fatigue syndrome and the potential immunological effects: a population-based retrospective cohort study.

Authors:  Tse-Yen Yang; Cheng-Li Lin; Wei-Cheng Yao; Chon-Fu Lio; Wen-Po Chiang; Kuan Lin; Chien-Feng Kuo; Shin-Yi Tsai
Journal:  J Transl Med       Date:  2022-02-21       Impact factor: 5.531

3.  The trends in the incidence and thrombosis-related comorbidities of antiphospholipid syndrome: a 14-year nationwide population-based study.

Authors:  Wei-Cheng Yao; Kam-Hang Leong; Chien-Feng Kuo; Lu-Ting Chiu; Po-Yi Chou; Li-Chih Wu; Chih-Yu Chou; Shin-Yi Tsai
Journal:  Thromb J       Date:  2022-09-01

Review 4.  The Gut Microbiome in Myalgic Encephalomyelitis (ME)/Chronic Fatigue Syndrome (CFS).

Authors:  Rahel S König; Werner C Albrich; Christian R Kahlert; Lina Samira Bahr; Ulrike Löber; Pietro Vernazza; Carmen Scheibenbogen; Sofia K Forslund
Journal:  Front Immunol       Date:  2022-01-03       Impact factor: 8.786

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.